KeithStuartMD

Oncology • Boston, MA

Gastrointestinal Cancer, Hematologic Oncology

Chair, Hematology/Oncology, Lahey Hospital & Medical Center,

Join to view full profile

Dr. Stuart is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Stuart's full profile

Already have an account?

Office
330 Brookline Ave
# 913D
Boston, MA 02215
Phone+1 617-667-9235

Fax+1 617-975-5665

Education & Training

Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1990 - 1991
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1988 - 1990
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1985 - 1988
Albert Einstein College of MedicineClass of 1985

Certifications & Licensure

NH State Medical License 2024 - 2026
MA State Medical License 1988 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Top MD Consumers Checkbook

Clinical Trials

Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver Start of enrollment: 1999 Dec 15
Completed
Phase 2
Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC) Start of enrollment: 2009 Feb 01
Withdrawn
Phase 2
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
Completed
Phase 3
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
Active, not recruiting
Phase 3
Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery Start of enrollment: 2014 Feb 01
Completed
Phase 2
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors Start of enrollment: 2018 Oct 26
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

8 citations
Capecitabine and oxaliplatin as first and second line treatment for locally advanced and metastatic pancreatic ductal adenocarcinoma
Andrea J. Bullock, Keith Stuart, Susanna Jacobus, Thomas A. Abrams, Raymond C. Wadlow
Journal of Gastrointestinal Oncology. 2017-07-26
121 citations
A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2, as first-line monotherapy in patients with advanced hepatocel...
Andrew X. Zhu, Richard S. Finn, Mary F. Mulcahy, Jayne Gurtler, Weijing Sun
Clinical Cancer Research. 2013-12-01
18 citations
Phase 1 study of N 1 ,N 11 ‑diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma
Lipika Goyal, Jeffrey G. Supko, Jordan Berlin, Lawrence S. Blaszkowsky, Amanda Carpenter
Cancer Chemotherapy and Pharmacology. 2013-10-12

Other

Overview of treatment approaches for hepatocellular carcinoma
Stuart KE, Abdalla EK
http://www.uptodate.com/contents/overview-of-treatment-approaches-for-hepatocellular-carcinoma
UpToDate, Wolters Kluwer Health - 2012-08-16
Treatment of localized cholangiocarcinoma: Surgical management and adjuvant therapy
Stuart KE, Anderson CD
http://www.uptodate.com/contents/treatment-of-localized-cholangiocarcinoma-surgical-management-and-a
UpToDate, Wolters Kluwer Health - 2013-03-28
Nonsurgical therapies for localized hepatocellular carcinoma: Radiofrequency ablation, percutaneous ethanol injection, thermal ablation, and cryoablation
Stuart KE, Schwartz JM, Carithers RL, Curley SA
http://www.uptodate.com/contents/nonsurgical-therapies-for-localized-hepatocellular-carcinoma-radiof
UpToDate, Wolters Kluwer Health - 2013-02-15
Nonsurgical therapies for localized hepatocellular carcinoma: Transarterial embolization, radiotherapy, and radioembolization
Stuart KE, Schwartz JM, Carithers RL, Curley SA
http://www.uptodate.com/contents/nonsurgical-therapies-for-localized-hepatocellular-carcinoma-transa
UpToDate, Wolters Kluwer Health - 2013-02-21
Systemic therapy for advanced cholangiocarcinoma
Stuart KE
http://www.uptodate.com/contents/systemic-therapy-for-advanced-cholangiocarcinoma
UpToDate, Wolters Kluwer Health - 2012-10-01
Systemic treatment for advanced hepatocellular carcinoma
Stuart KE
http://www.uptodate.com/contents/systemic-treatment-for-advanced-hepatocellular-carcinoma
UpToDate, Wolters Kluwer Health - 2013-02-21
Treatment options for locally advanced cholangiocarcinoma
Stuart KE, Anderson CD
http://www.uptodate.com/contents/treatment-options-for-locally-advanced-cholangiocarcinoma
UpToDate, Wolters Kluwer Health - 2012-04-17
Join now to see all

Press Mentions

First Thing: 'Petulant' Trump Wore Mask on Factory Visit – but Not in PublicMay 22nd, 2020
Lahey’s ‘Top Docs’ HonoredDecember 8th, 2017
He Expands Cancer Care in the SuburbsJanuary 15th, 2007
Join now to see all